- Motley Fool•3 days ago
A look through rose-colored glasses at Gilead Sciences' possible future.
- Forbes•10 days ago
Everytime Donald Trump tweets about drug prices, biotech stocks take it on the chin. Bruce Pile believes these episodes are giving informed investors good entry points for some of the best names in biotech.
- Zacks•10 days ago
Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||131.07 x 100|
|Ask||144.20 x 100|
|Day's Range||137.54 - 140.36|
|52 Week Range||67.52 - 153.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||259.06|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|